×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [12]
复旦大学上海医学院 [11]
中国医学科学院 北京... [7]
四川大学 [4]
山东大学 [3]
吉林大学白求恩第一医... [3]
更多...
内容类型
期刊论文 [50]
会议论文 [6]
学位论文 [1]
发表日期
2022 [6]
2021 [6]
2020 [2]
2019 [3]
2018 [7]
2017 [5]
更多...
学科主题
Oncology [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共57条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:
Wang, Wenxian
;
Lin, Gen
;
Guan, Yelan
;
Zhang, Yuxin
;
Xu, Chunwei
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/12/23
Thymic carcinoma
Immunotherapy
PD-1
Efficacy
Immune-related adverse events
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Li, Ning
;
Zhang, Youzhong
;
Wang, Jing
;
Zhu, Jianqing
;
Wang, Li
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2022/12/22
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements
期刊论文
LIVER CANCER, 2022, 卷号: 11
作者:
Sun, Yongkun
;
Zhang, Wen
;
Bi, Xinyu
;
Yang, Zhengqiang
;
Tang, Yu
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2022/12/23
Chinese interdisciplinary experts
Hepatocellular carcinoma
Molecular targeted therapy
Consensus
A phase Ib/II study of AK112, a PD-1/VEGF bispecific antibody, as first- or second-line therapy for advanced non-small cell lung cancer (NSCLC).
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Zhou, Caicun
;
Ren, Shengxiang
;
Luo, Yongzhong
;
Wang, Lei
;
Xiong, Anwen
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/12/23
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib
期刊论文
BMC CANCER, 2022, 卷号: 22
作者:
Jin, Ying
;
Lin, Chen
;
Shi, Xun
;
He, Qiong
;
Yan, Junrong
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/12/23
Clinical and molecular features
Efficacy and outcome
EGFR T790M mutation
Non-small-cell lung cancer
Osimertinib
Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review
期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:
Lin, Yuxin
;
Zhu, Wei
;
Wu, Bingchen
;
Lan, Huiyin
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/05/16
Sarcoid-like reaction
immune checkpoint inhibitor
Toripalimab
PD-1
case report
Resting-state functional connectivity of the amygdala subregions in unmedicated patients with obsessive-compulsive disorder before and after cognitive behavioural therapy
期刊论文
JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2021, 卷号: 46, 期号: 6, 页码: E628-E638
作者:
Gao, Jian
;
Yang, Xiangyun
;
Chen, Xiongying
;
Liu, Rui
;
Wang, Pengchong
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2021/12/27
A design implementation of the Central Process Module for an In-Beam PET in HICTD
期刊论文
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2021, 卷号: 1013, 页码: 7
作者:
Ke, L. Y.
;
Yan, J. W.
;
Chen, J. D.
;
Zhang, X. L.
;
Wang, C. X.
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2021/12/08
Data Concentrator
In-Beam PET
Field programmable gate array (FPGA)
Parallel sorters
Coincidence events detection
Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies
期刊论文
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021
作者:
Wang, Zeng
;
Jiang, Liyu
;
Yan, Hao
;
Xu, Zhifei
;
Luo, Peihua
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2021/04/26
Adverse events
chronic myeloid leukemia
management
mechanisms
molecular target
nilotinib
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China
期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:
Zhang, Xiangyu
;
Zeng, Liang
;
Li, Yizhi
;
Xu, Qinqin
;
Yang, Haiyan
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2021/03/15
Anlotinib
Immunotherapy
Programmed death 1 inhibitor
Lung cancer
©版权所有 ©2017 CSpace - Powered by
CSpace